Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 1, 2007

DuPont Invests $22.5M in First R&D Center in India

  • DuPont plans to invest over $22.5M to construct its first R&D center in India. The DuPont Knowledge Center will be located in Hyderabad and is expected to accommodate more than 300 scientists and other employees.

    "The DuPont Knowledge Center in India will focus on discovery research as well as applications development in a variety of areas," says DuPont senior vp and chief science and technology officer, Uma Chowdhry, Ph.D.

    DuPont has signed a Memorandum of Understanding with ICICI Knowledge Park for a long-term lease that will allow DuPont to construct its own R&D facility on 15 acres of land. The groundbreaking is slated for March and is expected to be fully operational in early 2008.

    Research at the site will focus on integrated science to develop the company's application pipeline in India and other emerging markets. The site initially will focus on molecular biology, bio-informatics, and polymer synthesis, with further R&D in the company's application pipeline across all five of its business growth platforms.


Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »